AIM ImmunoTech Inc - Company Profile
Powered by 
All the sales intelligence you need on AIM ImmunoTech Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how AIM ImmunoTech Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with AIM ImmunoTech Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on AIM ImmunoTech Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4096675A4 | Search Report | Zusammensetzungen und verfahren zur behandlung von long covid | C12N15/117; C12N2310/17; A61K31/713; A61K9/0043; A61P25/00; A61P31/12; A61P31/14; Y02A50/30 | December 06, 2023 |
| ZA202201633B | Grant | Compositions and methods for treating cancer | C12N15/117; C12N2310/17; C12N2320/31; A61K31/282; A61K31/4745; A61K31/513; A61K31/519; A61K31/7068; A61K31/713; A61P1/18; A61P35/00 | November 29, 2023 |
| ZA202207168B | Grant | Therapeutic double stranded rna and methods for producing the same | A61K31/713; A61P31/14; C07H21/02 | November 29, 2023 |
| US11813279B2 | Grant | Compositions for cancer therapy and methods | A61K2039/505; A61K31/713; A61K38/212; A61K39/3955; A61K9/0019; A61P35/00 | November 14, 2023 |
| US11813281B2 | Grant | Methods for improving exercise tolerance in myalgic encephalomyelitis patients | A61K31/713; A61K47/61; A61K47/645; A61P21/06 | November 14, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer